106 related articles for article (PubMed ID: 3465441)
1. Blood group substance, CEA, and lectins in ovarian tumors.
Dietel M; Arps H; Hölzel F; Viale G; Dell'Orto P; Kröger A; Niendorf A
Cancer Detect Prev; 1986; 9(5-6):511-20. PubMed ID: 3465441
[TBL] [Abstract][Full Text] [Related]
2. Distribution of carcinoembryonic antigens and blood group substances in adenocarcinoma of the colon.
Wiley EL; Mendelsohn G; Eggleston JC
Lab Invest; 1981 Jun; 44(6):507-13. PubMed ID: 7015005
[TBL] [Abstract][Full Text] [Related]
3. Ovarian tumors of low malignant potential (borderline tumors): immune morphology and current status.
Neunteufel W; Gitsch G; Schieder K; Kölbl H; Breitenecker G
Anticancer Res; 1989; 9(4):993-7. PubMed ID: 2684001
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
Oishi T; Maruo T; Iwasaki M; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
[TBL] [Abstract][Full Text] [Related]
6. Distribution of blood group antigens A, B, H, Lewisa, and Lewisb in human normal, fetal, and malignant colonic tissue.
Yuan M; Itzkowitz SH; Palekar A; Shamsuddin AM; Phelps PC; Trump BF; Kim YS
Cancer Res; 1985 Sep; 45(9):4499-511. PubMed ID: 4028031
[TBL] [Abstract][Full Text] [Related]
7. S-100 protein in ovarian tumors. A comparative immunohistochemical study of 135 cases.
Lin M; Hanai J; Wada A; Ozaki M; Nasu K; Okamoto S; Matsumoto K
Acta Pathol Jpn; 1991 Mar; 41(3):233-9. PubMed ID: 2068948
[TBL] [Abstract][Full Text] [Related]
8. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
9. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of carcinoembryonic antigen and periodic acid-Schiff stains in the diagnosis of serous and mucinous ovarian tumors: morphometrical study.
Aalto ML; Selkäinaho K; Collan Y
Appl Pathol; 1986; 4(1-2):83-9. PubMed ID: 3034311
[TBL] [Abstract][Full Text] [Related]
11. [Borderline tumors of the ovary. New aspects on morphologic prognosis determination].
Dietel M; Bodecker R; Arps H; Bahnsen J; Hölzel F
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):213-9. PubMed ID: 3891502
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical characterization of ovarian borderline tumors of intestinal and mullerian types.
Rutgers JL; Bell DA
Mod Pathol; 1992 Jul; 5(4):367-71. PubMed ID: 1495942
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localisation of carcinoembryonic antigen (CEA) in malignant epithelial ovarian tumours using monoclonal antibodies.
Gogate N; Deshmukh S
Indian J Pathol Microbiol; 1995 Apr; 38(2):199-201. PubMed ID: 8919110
[TBL] [Abstract][Full Text] [Related]
14. Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis.
Ilantzis C; Jothy S; Alpert LC; Draber P; Stanners CP
Lab Invest; 1997 May; 76(5):703-16. PubMed ID: 9166289
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia.
Kalir T; Wang BY; Goldfischer M; Haber RS; Reder I; Demopoulos R; Cohen CJ; Burstein DE
Cancer; 2002 Feb; 94(4):1078-82. PubMed ID: 11920478
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen in human ovarian neoplasms.
Marchand A; Fenoglio CM; Pascal R; Richart RM; Bennett S
Cancer Res; 1975 Dec; 35(12):3807-10. PubMed ID: 1192434
[TBL] [Abstract][Full Text] [Related]
17. Comparison of biochemical markers between benign and malignant ovarian cysts.
Knight JA; Wu JT; Miya T; Knight DP
Clin Physiol Biochem; 1986; 4(2):130-5. PubMed ID: 3516514
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase 2 expression in serous tumors of the ovary.
Singhal PK; Spiegel G; Driscoll D; Odunsi K; Lele S; Rodabaugh KJ
Int J Gynecol Pathol; 2005 Jan; 24(1):62-6. PubMed ID: 15626918
[TBL] [Abstract][Full Text] [Related]
19. Human ovarian tumors express gamma-glutamyl transpeptidase.
Hanigan MH; Frierson HF; Brown JE; Lovell MA; Taylor PT
Cancer Res; 1994 Jan; 54(1):286-90. PubMed ID: 7903206
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated alterations of blood group antigen expression in the human pancreas.
Itzkowitz SH; Yuan M; Ferrell LD; Ratcliffe RM; Chung YS; Satake K; Umeyama K; Jones RT; Kim YS
J Natl Cancer Inst; 1987 Sep; 79(3):425-34. PubMed ID: 2442445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
